Analytical Quality by Design with the Lifecycle Approach: A Modern Epitome for Analytical Method Development

1. ICH Expert Working Group. International Conference on Harmonization (ICH), Tripartite guidelines, ICHQ8(R2): Pharmaceutical Development. 2009. London.Search in Google Scholar

2. Zlota, “Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing, “Three-day course presented at ZLOTA Company LLC in conjunction with Scientific Update LLP, http://www.scientificupdate.co.uk/training/scheduledtraining-courses/details/216-actical%20Approaches%20to%20Quality%20by%20Design%20for%20Pharmaceutical%20Process%20R.html’DandManufacturing.Search in Google Scholar

3. Phil JB, John R, Chris J, Melissa HB, Roman S, Simon B. The development phase of an LC method using QbD principles. Journal of Separation Science.2010; 2: 2–8.Search in Google Scholar

4. Monika LJ, Santosh RT. Implementation of QbD approach to the analytical method development and validation for the estimation of propafenone hydrochloride in tablet dosage form. Chromatography Research International. 2013; 2013:1-9.10.1155/2013/676501Search in Google Scholar

5. Ferreira AP, Gamble JF, Leane MM, Park H, Olusanmi D, Tobyn M. Enhanced Understanding of Pharmaceutical Materials Through Advanced Characterisation and Analysis. AAPS PharmSciTech. 2018;19(8):3462-3480.10.1208/s12249-018-1198-630411240Search in Google Scholar

6. Taevernier L, Wynendaele E, D Hondt M, De Spiegeleer B. Analytical quality-by-design approach for sample treatment BSA-containing solutions. Journal of Pharmaceutical Analysis. 2015;5(1):27–32.10.1016/j.jpha.2014.06.001576146829403912Search in Google Scholar

7. USP Validation and verification expert panel. Proposed New USP General Chapter: The Analytical Procedure Lifecycle 〈1220〉. United State Pharmacopeial Convention (USP). Pharmacopeial forum. 2017;43 (1).Search in Google Scholar

8. Zhang L, Shirui M. Application of quality by design in the current drug development. Asian Journal of Pharmaceutical Sciences.2017;12:1–8.10.1016/j.ajps.2016.07.006703218332104308Search in Google Scholar

9. Pallagi E, Ambrus R, Szabó-Révész P, Csóka I. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation. Int J Pharm. 2015;491(1-2):384-92.10.1016/j.ijpharm.2015.06.01826134895Search in Google Scholar

10. Peraman R, Bhadraya K, Padmanabha RY. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. International Journal of Analytical Chemistry.2015; 2015:1-9.10.1155/2015/868727433298625722723Search in Google Scholar

11. Rohin M, Anurag SR. quality by design: an overview of the basic concepts, quality by design for biopharmaceuticals. John Wiley & Sons, Inc., Publication. Hoboken, NJ, 2009,1-20.10.1002/9780470466315.ch1Search in Google Scholar

12. Phil N, Phil JB, Tony B, Greg M, Pauline M. QbD for Better Method Validation and Transfer. http://www.pharmamanufacturing.com/articles/2010/060.html. 2010.Search in Google Scholar

13. George LR, Guilong C, David TF et al. Reversed-phase liquid chromatographic method development in an analytical quality by design framework. Journal of Liquid Chromatography and Related Technologies. 2013; 36(18): 2612–2638.10.1080/10826076.2013.765457Search in Google Scholar

14. Bhusnure OG, Gandge NV, Gholve SB. Sugave BK, Giram PS. A Review on Application of Quality by Design Concept to Analytical Method Development. Ijppr.Human, 2017; Vol. 10 (1): 63-75.Search in Google Scholar

15. USP Validation and verification expert panel. Lifecycle management of analytical procedures: method development, procedure performance qualification, and procedure performance verification. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2013; 39(5).Search in Google Scholar

16. Vogt FG, Kord AS. Development of quality-by-design analytical methods. J Pharm Sci. 2011; 100:797-812.10.1002/jps.2232521280050Search in Google Scholar

17. Lynn DT. OOS, OOT, OOC, and OOSC. Pharmaceutical Technology. 2011; 35(10):46–47.Search in Google Scholar

18. N. V. V. S. S. Raman, Useni RM, Hanimi RB.Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance Manufacturing. Journal of Chemistry. 2015; 2015:1-8.10.1155/2015/435129Search in Google Scholar

19. Mayank N, Panwar KS, Chopra VS, Indu B, Trivedi P. Quality by design: a systematic approach to pharmaceutical development. Der Pharmacia Lettre. 2010; 2:111-3.Search in Google Scholar

20. ICH. Q8 (R2) Pharmaceutical development. 2009. http://www.ich.org/fileadmin/PublicWebSite/ICHProducts/Guidelines/Quality/Q8R1/Step4/Q8R2Guideline.pdf. Accessed 26 April 2013.Search in Google Scholar

21. Bettencourt DS., Bulska E, Godlewska-Żyłkiewicz B, et al. Analytical measurement: measurement uncertainty and statistics, European Commission -Joint Research Centre, Luxembourg, Publications Office of the European Union,2013: 19-85.Search in Google Scholar

22. USP Validation and verification expert panel. Analytical target profile: Structure and Application throughout the analytical lifecycle. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2016; 42 (5).Search in Google Scholar

23. USP Validation and verification expert panel. Measurement Uncertainty for the Pharmaceutical Industry. Pharmacopeial Forum. 2018; 44(1).Search in Google Scholar

24. Quality Risk Management Q9, ICH Harmonised Tripartite Guideline, 2005.Search in Google Scholar

25. David V, Miroslav K. selected overview of risk assessment techniques, Problemy eksploatacji. 2009:19-32.Search in Google Scholar

26. Balaji J, Murugesh S. Analytical Quality by Design – A Legitimate Paradigm for Pharmaceutical Analytical Method Development and Validation. Mechanics, Materials Science & Engineering. 2017;9. Doi 10.2412/mmse.96.97.27610.2412/mmse.96.97.276Open DOISearch in Google Scholar

27. Varanasi UB, B. D. C. N. Prasad. A Framework for Auditing the Evaluation of Uncertainty for Compliance in Information Systems. Lecture Notes on Software Engineering.2015; 3(1).10.7763/LNSE.2015.V3.162Search in Google Scholar

28. Deviation Handling and Quality Risk Management, World Health Organization (WHO), A note for guidance for the manufacture of prequalified vaccines for supply to United Nations agencies Geneva, Switzerland, July 2013.Search in Google Scholar

29. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry.July 2015.Search in Google Scholar

30. Mogal V, Dusane J, Borase P, Thakare P, Kshirsagar S. A review on quality by design, Mogal V. et al. Pharmaceutical and Biological Evaluations 2016; vol. 3 (3): 313-319.Search in Google Scholar

31. Meitz A, Sagmeister P, Langemann T, Herwig C. An Integrated Downstream Process Development Strategy along QbD Principles, Bioengineering 2014; 1, 213-230.10.3390/bioengineering104021328955025Search in Google Scholar

32. Kochling J, Wu W, Hua Y, Guan Q, Castaneda-Merced J. A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. J Pharm Biomed Anal. 2016; 125:130-9.10.1016/j.jpba.2016.03.03127017571Search in Google Scholar

33. Priyanka PP, Sadikali FS, Machindra JC, Sanjay RC. Quality by design in analytical method development and validation. Journal of Environment and Life Science.2017;2:39-45.Search in Google Scholar

34. M. Deepa, K. Ravindra Reddy, S. V. Satyanarayana. A Review on Quality by Design Approach for Analytical Method Development. Journal of Pharmacy Research 2017;11(4):272-277.Search in Google Scholar

35. U.S. Food and Drug Administration CDER. Guidance for industry: PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. 2004.Search in Google Scholar

36. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding Pharmaceutical Quality by Design. AAPS J.2014;16(4): 771–783.10.1208/s12248-014-9598-3407026224854893Search in Google Scholar

37. USP Validation and verification expert panel. Analytical Control Strategy. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2016; 42(5).Search in Google Scholar

38. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. Vol. 2, Good manufacturing practices and inspection. – 2nd ed.Search in Google Scholar

39. Le Blond D., Weitzel J., Burdick R. Analytical Quality by Design Approach to the Development Stage in the Lifecycle of an Analytical Procedure. web’ Institute of Validation Technology, IVT Network. 2017Search in Google Scholar

40. Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R. Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr. Sci.2011;49(6):439-46.10.1093/chrsci/49.6.439Search in Google Scholar